| human Carbonic Anhydrase I in complex with 3,4-dihydro-1H-benzo[c][1,2]oxaborinin-1-ol | | homo-2-mer | 5-261 | 100 | 2×ZN; 2×KIX; 1×NA; |
|
| human carbonic anhydrase I in complex with 1-benzyl-3-(1-hydroxy-3,4-dihydro-1H-benzo[c][1,2]oxabor… | | homo-2-mer | 5-261 | 100 | 2×ZN; 2×WHK; |
|
| DRUG-PROTEIN INTERACTIONS: STRUCTURE OF SULFONAMIDE DRUG COMPLEXED WITH HUMAN CARBONIC ANHYDRASE I | | monomer | 2-261 | 100 | 1×ZN; 1×MZM; |
|
| DRUG-PROTEIN INTERACTIONS: STRUCTURE OF SULFONAMIDE DRUG COMPLEXED WITH HUMAN CARBONIC ANHYDRASE I | | monomer | 2-261 | 100 | 1×ZN; 5×HG; 1×AAS; |
|
| Human carbonic anhydrase I in complex with Methyl 2-(benzenesulfonyl)-4-chloro-5-sulfamoylbenzoate | | monomer | 4-261 | 100 | 1×ZN; 1×84Z; 8×EDO; 2×ACT; 3×PEG; |
|
| Human Carbonic Anhydrase I in complex with clorsulon | | monomer | 4-261 | 100 | 1×ZN; 1×7TI; |
|
| Crystal structure of human carbonic anhydrase isozyme I with 2,3,5,6-Tetrafluoro-4-(propylthio)benz… | | monomer | 4-261 | 100 | 1×ZN; 1×3TV; 1×PEG; 1×ACT; |
|
| Structure of inhibitor binding to Carbonic Anhydrase I | | monomer | 4-261 | 100 | 1×ZN; 1×M25; |
|
| ENZYME-SUBSTRATE INTERACTIONS: STRUCTURE OF HUMAN CARBONIC ANHYDRASE I COMPLEXED WITH BICARBONATE | | monomer | 4-261 | 100 | 1×ZN; 1×BCT; |
|
| Structure of inhibitor binding to Carbonic Anhydrase I | | monomer | 4-261 | 100 | 1×ZN; 1×M28; 1×TRS; |
|
| Crystal structure of human carbonic anhydrase isozyme I with 2,3,5,6-Tetrafluoro-4-piperidin-1-ylbe… | | monomer | 4-261 | 100 | 1×ZN; 1×3UG; |
|
| Structure of inhibitor binding to Carbonic Anhydrase I | | monomer | 4-261 | 100 | 1×ZN; 1×M29; 1×DMS; |
|
| DRUG-PROTEIN INTERACTIONS: STRUCTURE OF SULFONAMIDE DRUG COMPLEXED WITH HUMAN CARBONIC ANHYDRASE I | | monomer | 4-261 | 100 | 1×ZN; 1×AZM; |
|
| Human carbonic anhydrase I complexed with 4-(3-ethylureido)benzenesulfonamide | | monomer | 5-261 | 100 | 1×ZN; 1×UE7; |
|
| Crystal structure of human carbonic anhydrase I in complex with the 4-({[4-chloro-3-(trifluoromethy… | | monomer | 5-261 | 100 | 1×ZN; 2×ACT; 2×GOL; 1×GZE; |
|
| crystal structure of human carbonic anhydrase I in complex with 4-(3-(2-((2-fluorobenzyl)amino)ethy… | | monomer | 5-261 | 100 | 1×ZN; 1×O5T; |
|
| Crystal structure of human carbonic anhydrase I in complex with the 1-(2-hydroxy-5-sulfamoylphenyl)… | | monomer | 5-261 | 100 | 1×ZN; 1×CJK; 2×ACT; 1×GOL; |
|
| Crystal structure of human carbonic anhydrase I in complex with the 1-[4-chloro-3-(trifluoromethyl)… | | monomer | 5-261 | 100 | 1×ZN; 1×GZH; 1×GOL; 1×ACT; |
|
| human carbonic anhydrase I complexed with 4-(3-butylureido)benzenesulfonamide | | monomer | 5-261 | 100 | 1×DMS; 1×ZN; 1×U7M; |
|
| Crystal structure of human carbonic anhydrase I in complex with 4-(3-(2-((4-bromo-2-hydroxybenzyl)a… | | monomer | 5-261 | 100 | 1×ZN; 1×O55; |
|
| Crystal structure of human carbonic anhydrase I in complex with the 4-(4 acetyl-3-benzylpiperazine-… | | monomer | 5-261 | 100 | 1×ZN; 1×BZW; 1×GOL; 1×ACT; |
|
| Crystal structure of human carbonic anhydrase I in complex with 4-(3-(2-((4-fluorobenzyl)amino)ethy… | | monomer | 5-261 | 100 | 1×ZN; 1×O5K; |
|
| crystal structure of human carbonic anhydrase I in complex with 4-(3-(2-((2-fluorobenzyl)amino)ethy… | | monomer | 5-261 | 100 | 1×ZN; 1×O4Z; |
|
| crystal structure of human carbonic anhydrase I in complex with 4-(3-(2-((2-fluorobenzyl)amino)ethy… | | monomer | 5-261 | 100 | 1×ZN; 1×O5H; |
|
| Crystal structure of human carbonic anhydrase I in complex with the 4-[(3S)-3 benzyl-4-(4-sulfamoyl… | | monomer | 5-261 | 100 | 1×ZN; 1×N19; 1×ACT; 1×GOL; |
|
| human carbonic anhydrase I in complex with 2-((5-cyano-4-hydroxy-6-(p-tolyl)pyrimidin-2-yl)thio)-N-… | | monomer | 5-261 | 100 | 1×ZN; 1×WZH; |
|
| crystal structure of human carbonic anhydrase I in complex with 4-(3-(2-((2-fluorobenzyl)amino)ethy… | | monomer | 5-261 | 100 | 1×ZN; 1×O5N; |
|
| Crystal structure of human carbonic anhydrase I in complex with the 1-(2-hydroxy-5-sulfamoylphenyl)… | | monomer | 5-261 | 100 | 1×ZN; 1×GOL; 1×EON; |
|
| Crystal structure of human carbonic anhydrase I in complex with the 3-(2,5-dimethylphenyl)-1-(2-hyd… | | monomer | 5-261 | 100 | 1×ZN; 1×D3B; 2×GOL; |
|
| Carbonic anhydrase activators. The first X-ray crystallographic study of an activator of isoform I,… | | monomer | 5-261 | 100 | 1×ZN; 1×HIS; |
|
| THE CRYSTAL STRUCTURE OF THE ZINC(II) ADDUCT OF THE CAI MICHIGAN 1 VARIANT | | monomer | 5-261 | 99.61 | 3×ZN; 1×CL; 1×EDO; |
|
| Crystal structure of human Carbonic anhydrase I in complex with polmacoxib | | monomer | 5-261 | 100 | 1×ZN; 3×949; |
|
| DIFFERENCES IN ANIONIC INHIBITION OF HUMAN CARBONIC ANHYDRASE I REVEALED FROM THE STRUCTURES OF IOD… | | monomer | 5-261 | 100 | 1×ZN; 5×IOD; |
|
| Solution Structure of the CAI Michigan 1 Variant | | monomer | 5-261 | 99.61 | 1×ZN; 1×EDO; |
|
| Human carbonic anhydrase I covalently bound to AV21-08 | | monomer | 5-260 | 100 | 1×ZN; 1×PPI; 1×TRS; 1×DMS; 3×EDO; 1×VV8; |
|
| Crystal structure of human carbonic anhydrase isozyme I with 3-(cyclooctylamino)-2,5,6-trifluoro-4-… | | monomer | 6-261 | 100 | 1×ZN; 1×V14; 1×ACT; |
|
| Human Carbonic Anhydrase I in complex with 3,4-dihydro-1H-benzo[c][1,2]oxaborinin-1-ol pH 7.0 | | monomer | 6-261 | 100 | 1×ZN; 1×ACT; 1×KIX; |
|
| Azosemide in complex with Carbonic Anhydrase I | | monomer | 6-261 | 100 | 1×ZN; 1×DMS; 1×IWE; |
|
| Human Carbonic Anhydrase I complexed with a two-prong inhibitor | | monomer | 6-261 | 100 | 1×ZN; 3×B30; |
|
| Human Carbonic Anhydrase I in complex with veralipride | | monomer | 6-261 | 100 | 1×ZN; 1×A1H1P; |
|
| Selenols: a new class of Carbonic Anhydrase inhibitors | | monomer | 6-261 | 100 | 1×ZN; 1×GXE; |
|
| Crystal structure of human carbonic anhydrase I in complex with the inhibitor famotidine | | monomer | 6-261 | 100 | 1×ZN; 1×FO9; |
|
| Crystal structure of human carbonic anhydrase isozyme I with 4-[(2-Hydroxyethyl)thio]benzenesulfona… | | monomer | 6-261 | 100 | 1×ZN; 1×3UF; 1×ACT; |
|
| Human Carbonic Anhydrase I in complex with benzoselenoate | | monomer | 6-261 | 100 | 1×ZN; 1×E7I; |
|
| Human Carbonic Anhydrase I in complex with 4-(5-acetyl-6-methyl-2-oxo-1,2,3,4-tetrahydropyrimidin-4… | | monomer | 6-261 | 100 | 1×ZN; 1×V2I; |
|
| Human Carbonic Anhydrase I in complex with topiramate | | monomer | 6-261 | 100 | 1×ZN; 1×TOR; |
|
| Differences in anionic inhibition of Human Carbonic Anhydrase I revealed from the structures of iod… | | monomer | 6-261 | 100 | 1×ZN; 4×AUC; |
|
| X ray structure of the complex between Carbonic Anhydrase I and the phosphonate antiviral drug fosc… | | monomer | 6-261 | 100 | 1×ZN; 1×PPF; |
|
| STRUCTURE AND FUNCTION OF CARBONIC ANHYDRASES | | monomer | 6-261 | 99.22 | 4×HG; 2×CL; 1×H2S; |
|
| STRUCTURE, REFINEMENT AND FUNCTION OF CARBONIC ANHYDRASE ISOZYMES. REFINEMENT OF HUMAN CARBONIC ANH… | | monomer | 6-261 | 99.22 | 1×ZN; |
|
| Crystal structure of 19F probe-labeled hCAI | | monomer | 6-261 | 100 | 1×FLB; 1×ZN; |
|
| selenol bound carbonic anhydrase I | | monomer | 6-261 | 100 | 1×ZN; 1×LVW; |
|
| Crystal structure of 19F probe-labeled hCAI in complex with acetazolamide | | monomer | 6-261 | 100 | 1×FLB; 1×ZN; 1×AZM; |
|